.In attempting to quantify its attitude toward risk, top management of the pharmaceutical company has reported certainty equivalent values for a variety of 50-50 risks. These are summarized in the following table. Outcome of 50-50 Risk Certainty Equivalent $200 and $0 $ 50 $200 and $50 112 $50 and $0 13 $200 and $112 153 $112 and $50 70 $50 and $13 28 $112 and $13 50 For instance, the company's CE for a 50-50 risk between $200 million and $0 is $50 million, and so on. a. Use these responses to determine utility values for each of the monetary valucs in the sccond column. (Hint: Set U($200) = 100 and U($0) = 0. Show that U($50) = 50, U($112) = 75, and so on.) Construct a utility graph by plotting points and drawing a smooth curve. (You may wish to check the utility values in Problem 13 against your curve.) *b. Consider the mathematical utility function U = 7.1Vy, where U is the utility value corresponding to monetary outcome y. Check that this function is an accurate description of the pharmaceutical company's attitude toward risk. Is the company very risk averse?

.In attempting to quantify its attitude toward risk, top management of the pharmaceutical company has reported certainty equivalent values for a variety of 50-50 risks. These are summarized in the following table. Outcome of 50-50 Risk Certainty Equivalent $200 and $0 $ 50 $200 and $50 112 $50 and $0 13 $200 and $112 153 $112 and $50 70 $50 and $13 28 $112 and $13 50 For instance, the company's CE for a 50-50 risk between $200 million and $0 is $50 million, and so on. a. Use these responses to determine utility values for each of the monetary valucs in the sccond column. (Hint: Set U($200) = 100 and U($0) = 0. Show that U($50) = 50, U($112) = 75, and so on.) Construct a utility graph by plotting points and drawing a smooth curve. (You may wish to check the utility values in Problem 13 against your curve.) *b. Consider the mathematical utility function U = 7.1Vy, where U is the utility value corresponding to monetary outcome y. Check that this function is an accurate description of the pharmaceutical company's attitude toward risk. Is the company very risk averse?

ENGR.ECONOMIC ANALYSIS

14th Edition

ISBN:9780190931919

Author:NEWNAN

Publisher:NEWNAN

Chapter1: Making Economics Decisions

Section: Chapter Questions

Problem 1QTC

See similar textbooks

Similar questions

Discuss: i) diversifiable risk; ii) market risk; iii) systematic risk iv) unsystematic risk;
2 Prove rigourously, "Constant relative risk aversion (CRRA) implies decreasing absolute risk aversion (DARA), but the converse is not necessarily true."
None
3. The risk free rate is 3%. The optimal risky portfolio has an expected return of 9% and standard deviation of 20%. Answer the following questions. (a) Assume the utility function of an investor is U = E(r) − 0.5Aσ2. What is condition of A to make the investors prefer the optimal risky portfolio than the risk free asset? (b) Assume the utility function of an investor is U = E(r) − 2.5σ2. What is the expected return and standard deviation of the investor’s optimal complete portfolio?
advanced microeconomics, uncertainty
What term do economists use to describe the tendency for people to prefer certain outcomes over risky situations? a. The precautionary principle b. Risk differentiationc. Risk uncertainty d. Risk aversion e. Risk management
Required Return If the risk-free rate is 3 percent and the risk premium is 5 percent, what is the required return?